RougeTx

RougeTx develops small molecule drugs to treat microvascular bleeding diseases, starting in Hereditary Hemorrhagic Telangiectasia

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

RougeTx develops small molecule drugs to treat microvascular bleeding diseases, starting in Hereditary Hemorrhagic Telangiectasia.

02Backed By1 investor

03Similar Companies

HT

Hemab Therapeutics

Biotech & Life Sciences

→

LT

SB

HT

PB

04Startup DNA

6

signals

Sectors
Business Model
Technology